000 01421 a2200397 4500
005 20250516024014.0
264 0 _c20110628
008 201106s 0 0 eng d
022 _a1865-8652
024 7 _a10.1007/s12325-010-0106-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFryzek, Jon P
245 0 0 _aTrends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.
_h[electronic resource]
260 _bAdvances in therapy
_cMar 2011
300 _a195-201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAge Distribution
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHospitalization
_xtrends
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aPalivizumab
650 0 4 _aRespiratory Syncytial Virus Infections
_xdrug therapy
650 0 4 _aRespiratory Syncytial Viruses
_xisolation & purification
650 0 4 _aTime Factors
700 1 _aMartone, William J
700 1 _aGroothuis, Jessie R
773 0 _tAdvances in therapy
_gvol. 28
_gno. 3
_gp. 195-201
856 4 0 _uhttps://doi.org/10.1007/s12325-010-0106-6
_zAvailable from publisher's website
999 _c20604630
_d20604630